Efficient management of secondary haemophagocytic lymphohistiocytosis with intravenous steroids and γ-immunoglobulin infusions

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 21

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Nov 6, 2019; 7(21): 3394-3406
Published online Nov 6, 2019. doi: 10.12998/wjcc.v7.i21.3394

Full Size Figure Download Figure

Figure 1 Underlying cause of the secondary haemophagocytic lymphohistiocytosis according to the age of patients.

Citation: Georgiadou S, Gatselis NK, Stefos A, Zachou K, Makaritsis K, Rigopoulou EI, Dalekos GN. Efficient management of secondary haemophagocytic lymphohistiocytosis with intravenous steroids and γ-immunoglobulin infusions. World J Clin Cases 2019; 7(21): 3394-3406
URL: https://www.wjgnet.com/2307-8960/full/v7/i21/3394.htm
DOI: https://dx.doi.org/10.12998/wjcc.v7.i21.3394

Georgiadou S, Gatselis NK, Stefos A, Zachou K, Makaritsis K, Rigopoulou EI, Dalekos GN. Efficient management of secondary haemophagocytic lymphohistiocytosis with intravenous steroids and γ-immunoglobulin infusions. World J Clin Cases 2019; 7(21): 3394-3406 [PMID: 31750324 DOI: 10.12998/wjcc.v7.i21.3394]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.